SCHEMBL21177013

SCHEMBL21177013

O=C(O)C/C=C/c1csc2cc(Br)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.47
PAM P19021 1/20 0.38
PDE5A O76074 2/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.34
GPR17 Q13304 1/20 0.34
MAOB P27338 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
MAOA P21397 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
LSS P48449 1/20 0.32
PRF1 P14222 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29452875 1.00 CYP2A6 (0.47) CYP2A6PAMPDE5APTGDR2GPR17
SCHEMBL21187253 0.81 CYP2A6 (0.54) CYP2A6MEN1ALDH1A1MAPTMAPK1
SCHEMBL6811552 0.74 CYP2A6 (0.74) CYP2A6PTGDR2ALDH1A1PRF1
SCHEMBL30197394 0.74 CYP2A6 (0.74) CYP2A6PTGDR2ALDH1A1PRF1
SCHEMBL2819310 0.72 PAM (0.43) PAMPDE5APTGDR2MAOBALDH1A1
SCHEMBL2819313 0.72 PAM (0.43) PAMPDE5APTGDR2MAOBALDH1A1
SCHEMBL6811378 0.70 CYP2A6 (0.50) CYP2A6ALDH1A1MAPTHDAC10HDAC11
SCHEMBL6811377 0.70 CYP2A6 (0.50) CYP2A6ALDH1A1MAPTHDAC10HDAC11
SCHEMBL498796 0.69 TBXAS1 (0.47) CYP2A6MEN1ALDH1A1KMT2AHDAC10
SCHEMBL25203677 0.67 PAM (0.68) PAMMAOBMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250058-B PPAR agonists and their use in the treatment of Alzheimer's disease and other diseases 上海怡立舍生物技术有限公司 2022-02-11 CN disclosed
WO-2019141229-A1 COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF 上海怡立舍生物技术有限公司 2019-07-25 WO disclosed
WO-2019141229-A1 COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF 上海怡立舍生物技术有限公司 2019-07-25 WO disclosed
CN-108250058-A PPAR agonists and their use in the treatment of Alzheimer's disease and other diseases 上海怡立舍生物技术有限公司 2018-07-06 CN disclosed